Cargando…
Statistical modelling of HER2-positivity in breast cancer: Final analyses from two large, multicentre, non-interventional studies in Germany
BACKGROUND: The German NIU HER2 model was developed based on five variables found to have statistically significant influences on HER2-positivity, to allow exploration of deviations between model-predicted and actual HER2-positivity rates as a measure of testing quality. The prospective, non-interve...
Autores principales: | Rüschoff, Josef, Lebeau, Annette, Sinn, Peter, Schildhaus, Hans-Ulrich, Decker, Thomas, Ammann, Johannes, Künzel, Claudia, Koch, Winfried, Untch, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375682/ https://www.ncbi.nlm.nih.gov/pubmed/31918324 http://dx.doi.org/10.1016/j.breast.2019.12.005 |
Ejemplares similares
-
Neue Therapiemöglichkeiten beim metastasierten HER2-low-Mammakarzinom: Konsequenzen für die histopathologische Diagnostik
por: Denkert, Carsten, et al.
Publicado: (2022) -
Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status
por: Rüschoff, Josef, et al.
Publicado: (2022) -
Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases
por: Lokka, Suvi, et al.
Publicado: (2014) -
Polarization correlations in the SLC final focus
por: Decker, Franz Josef
Publicado: (1996) -
B3-Läsionen der Mamma: Histologische, klinische und epidemiologische Aspekte: Update
por: Varga, Zsuzsanna, et al.
Publicado: (2023)